NYSE:VNEVeoneer Stock Price, Forecast & News

Veoneer's stock was trading at $8.99 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, VNE stock has increased by 30.8% and is now trading at $11.76. View which stocks have been most impacted by Coronavirus.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veoneer in the last year. There are currently 7 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Veoneer.

Veoneer is scheduled to release its next quarterly earnings announcement on Friday, July 24th 2020. View our earnings forecast for Veoneer.

Veoneer Inc (NYSE:VNE) issued its quarterly earnings data on Friday, April, 24th. The company reported ($1.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.34) by $0.15. The firm earned $362 million during the quarter, compared to analyst estimates of $359 million. Veoneer had a negative net margin of 33.63% and a negative return on equity of 29.08%. View Veoneer's earnings history.

Veoneer issued an update on its first quarter 2020 Pre-Market earnings guidance on Friday, March, 20th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $350-370 million, compared to the consensus revenue estimate of $390.09 million.

9 brokerages have issued 12 month target prices for Veoneer's stock. Their forecasts range from $9.00 to $26.00. On average, they expect Veoneer's stock price to reach $15.38 in the next year. This suggests a possible upside of 30.7% from the stock's current price. View analysts' price targets for Veoneer.

Media stories about VNE stock have been trending somewhat negative on Thursday, according to InfoTrie Sentiment. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Veoneer earned a news sentiment score of -1.7 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutVeoneer.

Some companies that are related to Veoneer include Allison Transmission (ALSN), LCI Industries (LCII), Dorman Products (DORM), Dana (DAN), Adient (ADNT), Meritor (MTOR), Gentherm (THRM), Delphi Technologies (DLPH), Standard Motor Products (SMP), American Axle & Manufact. (AXL), Tower International (TOWR), Stoneridge (SRI), IOCHPE MAXION S/S (IOCJY), Tenneco (TEN) and Garrett Motion (GTX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Veoneer investors own include Pfizer (PFE), Autoliv (ALV), Franklin Resources (BEN), Canadian Natural Resources (CNQ), Constellation Pharmaceuticals (CNST), California Resources (CRC), Dominion Energy (D), Delta Air Lines (DAL), Enterprise Products Partners (EPD) and Gilead Sciences (GILD).

Veoneer trades on the New York Stock Exchange (NYSE) under the ticker symbol "VNE."

Veoneer's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (1.92%), DNB Asset Management AS (1.59%), State Street Corp (0.37%), Invesco Ltd. (0.31%), JPMorgan Chase & Co. (0.29%) and Swiss National Bank (0.18%). Company insiders that own Veoneer stock include Arthur Blanchford, Jan Carlson, Mathias Hermansson and Mikko S Taipale. View institutional ownership trends for Veoneer.

VNE stock was sold by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Two Sigma Investments LP, Bank of New York Mellon Corp, Engineers Gate Manager LP, Tudor Investment Corp Et Al, Victory Capital Management Inc., and Victory Capital Management Inc.. View insider buying and selling activity for Veoneer.

VNE stock was purchased by a variety of institutional investors in the last quarter, including DNB Asset Management AS, JPMorgan Chase & Co., Invesco Ltd., Jane Street Group LLC, State Street Corp, Aigen Investment Management LP, FNY Investment Advisers LLC, and GSA Capital Partners LLP. Company insiders that have bought Veoneer stock in the last two years include Arthur Blanchford, Jan Carlson, Mathias Hermansson, and Mikko S Taipale. View insider buying and selling activity for Veoneer.

Shares of VNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of VNE stock can currently be purchased for approximately $11.76.

Veoneer has a market capitalization of $1.31 billion and generates $1.90 billion in revenue each year. The company earns $-500,000,000.00 in net income (profit) each year or ($4.92) on an earnings per share basis. Veoneer employs 8,600 workers across the globe.

The official website for Veoneer is www.veoneer.com.

Veoneer's mailing address is 26545 AMERICAN DRIVE, SOUTHFIELD MI, 48034. The company can be reached via phone at 248-223-0600 or via email at [email protected]